Pharmacologic interventions in resuscitation.
Pharmacologic agents are used to improve conditions that may contribute to the development of cardiac arrest such as dysrhythmias, hypotension, shock, or anoxia. The authors review the clinical application of several specific agents in resuscitation.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001285:Atropine / Q000627:therapeutic use; D001950:Bretylium Tosylate / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D006323:Heart Arrest / Q000188:drug therapy; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D012151:Resuscitation / Q000379:methods*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D002316:Cardiotonic Agents; D014662:Vasoconstrictor Agents; D009270:Naloxone; D004280:Dobutamine; D001950:Bretylium Tosylate; D001285:Atropine; D008012:Lidocaine; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine